专家述评

创新引领数智镇痛医疗规范化高质量发展

Guiding the development of digital analgesia technology standards with high standards of excellence and quality

:820-825
 
1994年中国引进患者自控镇痛(PCA),经过国人改造升级如今已取得了令人瞩目的成绩:2007年《术后患者自控镇痛临床研究与推广应用》获教育部科学技术进步奖二等奖和中华医学科技奖三等奖;2011年具有中国自主专利产权和创新数字医疗的智能化患者自控镇痛(Ai-PCA)诞生,2019年《智能化术后患者自控镇痛管理关键技术及其临床应用》获得中国抗癌协会科技奖二等奖;2023年《中国分娩镇痛规范及推广应用》获得华夏医学科技奖二等奖。笔者撰写述评,提出努力推进Ai-PCA高水平高质量发展的措施,呼吁国内学者重视引领数智镇痛医疗规范化,于2024年在《中华疼痛学杂志》刊出由余守章教授牵头制定的《患者自控镇痛临床应用规范专家共识》,助力中国数智镇痛医疗技术向智慧化前行,为人民群众切实享受到舒适镇痛提供更优质的服务。
Since the introduction of Patient-Controlled Analgesia(PCA)in China in 1994,the domain has witnessed its substantial advancements.The project,Clinical Research and Promotion of Postoperative Patient-Controlled Analgesia,achieved the Ministry of Education’s Second Prize for Scientific and Technological Progress and the Chinese Medical Association’s Third Prize in 2007.The innovation continued in 2011 with the development of an intelligent PCA system(Ai-PCA)endowed with Chinese independent patent rights and innovative digital medical technology.In 2019,the Key Technologies and Clinical Application of Intelligent Postoperative Patient-Controlled Analgesia Management was honored with the second-class Science and Technology Award by the Chinese Anti-Cancer Association.Furthering this trend.In 2023,the Standards and Promotion of Labor Analgesia in China secured the second-class prize in Medical Science and Technology from Huaxia Medical Science and Technology.This commentary suggest strategies for the qualitative enhancement of Ai-PCA and urge domestic scholars to spearhead the standardization of Ai-PCA.Expert Consensus on Clinical Application Standards for Patient-Controlled Analgesia leaded and edited by Pro.She has published,in 2024,which fervently supports the advancement of China’s Ai-PCA technology towards a more intelligent future,to provide the public with higher quality and more comfortable pain management services.
论著

布托啡诺联合舒芬太尼对ICU机械通气患者血流动力学及镇痛效果的影响

Effects of butorphanol combined with sufentanil on hemodynamics and analgesia in patients with mechanical ventilation in ICU

:164-169
 
目的 观察布托啡诺联合舒芬太尼镇痛方案在重症监护病房(ICU)机械通气患者中的效果及对血流动力学的影响。方法 采用前瞻性、随机对照研究,选取2021年3月—2023年3月商丘市第三人民医院ICU收治的118例机械通气患者,按1∶1随机分为观察组、对照组各59例。观察组采取布托啡诺联合舒芬太尼镇痛方案,对照组采取舒芬太尼镇痛方案。比较两组镇静、镇痛情况(镇静起效时间、停药后苏醒时间、机械通气时间、ICU住院时间、丙泊酚总用量)。以用药前(T0)、用药后6 h(T1)、12 h(T2)、24 h(T3)为时间节点,比较两组血流动力学指标[心率(HR)、平均动脉压(MAP)]。以用药后6 h(t1)、12 h(t2)、18 h(t3)、24 h(t4)为时间节点,比较两组Ricker镇静-躁动评分(SAS)、重症监护疼痛观察工具(CPOT)评分。比较两组不良反应发生情况。结果 用药后观察组镇静起效、停药后苏醒、机械通气、ICU住院时间均短于对照组,丙泊酚总用量少于对照组(P<0.05);t1~t4时观察组CPOT评分均低于对照组,SAS评分均高于对照组(P<0.05);T1、T2、T3时观察组HR、MAP波动幅度小于对照组(P<0.05);观察组不良反应总发生率为10.17%,与对照组15.25%相比,差异无统计学意义(P>0.05)。结论 布托啡诺、舒芬太尼联合治疗ICU机械通气患者,可有效增强镇静、镇痛效果,维持血流动力学稳定,且安全性较高,有利于促进患者病情转归。
Objective To observe the effect of butorphanol and sufentanil combined analgesia regimen in patients with mechanical ventilation in intensive care unit(ICU)and its influence on hemodynamics.Methods A prospective,randomized controlled study was carried out on 118 patients with mechanical ventilation in ICU from March 2021 to March 2023,and the enrolled patients were randomly divided into observation group and control group with 59 cases in each group.The observation group received butorphanol combined with sufentanil analgesia regimen,and the control group received sufentanil analgesia regimen.The conditions of sedation and analgesia(sedation onset time,recovery time after drug withdrawal,mechanical ventilation time,ICU stay length,total dosage of propofol)were compared between the two groups.The hemodynamic indexes [heart rate(HR)and mean arterial pressure(MAP)] of the two groups were compared before medication(T0),6 h(T1),12 h(T2)and 24 h(T3)after medication as time nodes.At 6 h(t1),12 h(t2),18 h(t3),24 h(t4)after medication,Ricker Sedation-Agitation Scale(SAS)and Critical Care Pain Observation Tool(CPOT)score were compared between the two groups.The occurrence of adverse reactions was compared between the two groups.Results The onset of sedation,recovery after drug withdrawal,mechanical ventilation and ICU stay in the observation group were shorter than those in the control group,and the total dosage of propofol was lower than that in the control group(P<0.05).At t1 to t4,CPOT score of observation group was lower than that of control group,and SAS score was higher than that of control group(P<0.05).The fluctuation amplitude of HR and MAP in the observation group was smaller than that in the control group at T1,T2 and T3(P<0.05).The total incidence of adverse reactions in the observation group was 10.17%,compared with 15.25% in the control group,the difference was not statistically significant(P>0.05).Conclusions The combination of butorphanol and sufentanil in the treatment of patients with mechanical ventilation in ICU can effectively enhance sedation and analgesia,maintain hemodynamic stability,and have high safety,which is conducive to promote the outcome of the disease.
论著

艾司氯胺酮对剖宫产术后镇痛及RAAS系统、产后抑郁的影响

Effects of esketamine on postoperative analgesia and RAAS system and postpartum depression after cesarean delivery

:51-55
 
目的 分析艾司氯胺酮对剖宫产术后镇痛及肾素-血管紧张素-醛固酮系统(RAAS)、产后抑郁情况发生的影响。方法 研究对象为2020年5月—2021年6月在我院行剖宫产的96例孕产妇,根据麻醉药物的不同分为研究组50例和对照组46例,2组孕产妇均给予腰硬联合麻醉行剖宫产术,研究组于手术切皮前5 min静脉注射艾司氯胺酮0.2 mg/kg,对照组静脉注射等量生理盐水。比较2组孕产妇术后疼痛评分(VAS评分)、肾素活性(PRA)、血管紧张素-II(AT-II)、醛固酮(ALD)、爱丁堡产后抑郁量表(EPDS)、不良反应的发生情况。结果 与对照组比较,术后各时间点研究组孕产妇VAS评分均明显较低,差异具有统计学意义(P<0.01)。2组T1、T2、T3各时间点RAAS各指标均明显低于T0时间点(P<0.05);研究组在T1、T2时间点RAAS各指标均明显低于对照组,差异具有统计学意义(P<0.05)。研究组术后3 d、术后6周EPDS评分均明显低于对照组(P<0.01)。2组不良反应总发生率比较无差异(P>0.05)。结论 艾司氯胺酮用于剖宫产术后镇痛效果显著,对产妇RAAS影响较小,并可缓解产妇抑郁症状,且不良反应发生率较低。
Objective To analyze the effect of esketamine on analgesia and renin angiotensin aldosterone system(RAAS)and the occurrence of postpartum depression after cesarean delivery.Methods The subjects were 96 pregnant women who underwent cesarean section in our hospital from May 2020 to June 2021,they were divided into 50 cases in the study group and 46 cases in the control group.Both groups of pregnant women were given combined spinal epidural anesthesia for cesarean section.The patients in study group were injected with esmketamine 0.2 mg/kg intravenously 5 minutes before skin incision,and those in control group were injected with the same amount of saline intravenously.The postoperative pain scores(VAS score),plasma renin activity(PRA),angiotensin-II(AT-II),aldosterone(ALD),Edinburgh Postpartum Depression Scale(EPDS),and the occurrence of adverse effects were compared between the two groups.Results Compared with the control group,maternal VAS scores were significantly lower in the study group at all postoperative time points,and the differences were statistically significant(P<0.01).The indexes of RAAS were significantly lower in both groups at T1,T2 and T3 time points than at T0 time point(P<0.05);the indexes of RAAS were significantly lower in the study group at T1 and T2 time points than in the control group,and the differences were statistically significant(P<0.05).The postoperative EPDS scores in the study group were significantly lower than those in the control group at 3 d and 6 weeks(P<0.01).There was no difference in the overall incidence of adverse reactions between the two groups(P>0.05).Conclusions Esketamine is effective for postoperative analgesia after cesarean section,with less effect on maternal RAAS,and can relieve maternal depressive symptoms,and has a low incidence of adverse reactions.
论著

腰硬联合分娩镇痛对初产妇产程进展及产时发热影响

Effect of combined spinal-epidural analgesia on labor progress and intrapartum fever in primipara

:46-51
 
目的 探讨腰-硬联合阻滞分娩镇痛方式对初产妇在产程进展及产时发热的影响,为临床实践提供理论依据。方法 回顾性分析2020年12月—2021年12月在广州市某三甲医院产科分娩产妇535例的基本资料。观察组(285例)采用腰-硬联合阻滞麻醉分娩镇痛,对照组(250例)选择常规无干预分娩。结果 观察组中的产妇第一产程和第二产程的时间比对照组更长,且产后2 h出血量高于对照组,差异有统计学意义(P<0.05),除此之外,2组产妇产时发热率比较差异也有统计学意义(P<0.01)。结论 腰硬联合阻滞分娩镇痛在一定程度上会延长产程,且产后2 h的出血量较多,同时也会增加产时发热的概率,存在一定不良反应,故需要密切观察,保证母儿安全。
Objective To investigate the effect of combined spinal-epidural block anesthesia on the progress of labor and intrapartum fever in primipara,and to provide a theoretical basis for clinical practice.Methods The basic data of 535 pregnant women who gave birth in the obstetrics department of a tertiary hospital in Guangzhou from December 2020 to December 2021 were retrospectively analyzed.The observation group(285 cases)was given labor analgesia,and the control group(250 cases)was given routine non-intervention delivery.Results The time of the first stage of labor and the second stage of labor in the observation group was significantly longer than that in the control group,and the bleeding volume 2 hours after delivery was higher than that in the control group,and the difference was statistically significant(P<0.05).The maternal fever rate during delivery also had statistical significance(P<0.01).Conclusions Combined spinal-epidural block anesthesia will prolong the labor process to a certain extent,and the amount of bleeding in 2 hours after delivery will be more,and it will also increase the probability of intrapartum fever,with certain adverse reactions.Therefore,close observation is needed to ensure the mother and child safety.
临床诊疗

肩关节镜手术中臂丛神经阻滞与关节腔内注射局麻药对术后镇痛的效果研究

The effect of arm nerve block and intraarticular injection of local anesthetic on postoperative analgesia in shoulder arthroscopic surgery

:134-137
 
目的 探讨臂丛神经阻滞和关节腔内注射局麻药联合应用在肩关节镜手术中的应用价值。方法 对肩关节镜手术患者100例进行研究,2018年8月—2020年8月入组,根据随机数字表法分组处理,对照组和观察组各为50例,前者用臂丛神经阻滞,后者与关节腔内注射局麻药联合,比较2组麻醉效果、不同阶段疼痛程度、肩关节功能。另对比2组不良反应。结果 观察组麻醉起效时间、苏醒时间和拔管时间分别为(10.72±2.45)min、(8.21±1.32)min和(9.52±1.12)min,与对照组对应指标有差异(P<0.05);2组术前疼痛程度和肩关节功能对比无差异(P>0.05),观察组术后6 h、术后24 h和术后48 h疼痛评分依次为(1.31±0.27)分、(2.87±0.52)分和(3.44±0.42)分,术后6 h、术后12 h、术后24 h和术后48 h镇静评分分别为(2.92±0.32)分、(2.54±0.24)分、(2.38±0.12)分和(2.27±0.15)分,术后1周、1个月和3个月的肩关节功能评分分别为(50.12±4.54)分、(56.18±4.12)分和(73.16±4.78)分,较之于对照组有差异(P<0.05);对照组和观察组出现不良反应的概率分别为18.00%和4.00%(P<0.05)。 结论 在肩关节镜手术中联合应用臂丛神经阻滞联合关节腔内注射局麻药麻醉方式,可提高麻醉效果,术后镇痛和镇静效果明显,也可减少不良反应,对患者肩关节功能改善作用明显,存在广泛应用价值。
论著

罗哌卡因浸润麻醉在胸腹腔镜联合食管癌根治术后镇痛疗效的临床观察

Clinical observation of ropivacaine infiltration anesthesia for analgesia after thoracoscopic and laparoscopic combined radical resection of esophageal cancer

:30-32
 
目的 研究罗哌卡因阻滞用于胸腹腔镜联合食管癌根治术后镇痛的临床效果。方法 胸腹腔镜联合食管癌根治术患者60例,分为: 观察组(n=30),缝合切口时用0.25%盐酸罗哌卡因10 mL于切口局部浸润;对照组(n=30) 不做局部浸润麻醉处理;记录二组术后2 h、6 h、12 h、24 h、48 h的疼痛视觉模拟评分(VAS)及血浆皮质醇浓度。结果 观察组术后2 h、6 h、12 h VAS评分优于对照组,术后12 h观察组血浆皮质醇浓度低于对照组。结论 罗哌卡因术终阻滞术后12 h内镇痛效果明显。
Objective To evaluate the efficiency of postoperative analgesia with ropivacaine block after thoracoscopic-lapacoscopic esophagectomy (TLE). Methods Totally 60 patients with esophageal cancer underwent TLE were divided into two groups: observation group(n=30)with 0.25% ropivacaine hydrochloride solution 10 mL injection around incision before end of the operation; control group(n=30)without the treatment. The VAS and the plasma Cortisol concentration at 2 h、6 h、12 h、24 h、48 h after surgery were recorded. Results The VAS at 2 h、6 h、12 h after surgery in observation group was higher than that of the control group,but not at 24 h、48 h after surgery. The plasma Cortisol concentration in the observation group was higher than that of in the control at 12 hours postoperatively. Conclusion Ropivacaine block of incision is helpful to have analgesic effect within 12 hours after TLE.
论著

剖宫产术后镇痛应用不同浓度罗哌卡因腹横肌平面阻滞的临床分析

Clinical analysis of different concentrations of ropivacaine transverses abdominis plane block for postoperative analgesia after cesarean section

:22-25
 
目的 比较不同浓度罗哌卡因横纹肌阻滞应用于剖宫产术后镇痛的临床效果。方法 选取2015年3月—2016年3月于我院剖宫产的孕妇300例,随机分为A组、B组、C组,每组100例,A组产妇给予质量浓度为1.5 g/L的罗哌卡因1.5 mg/kg,B组产妇给予质量浓度为2 g/L的罗哌卡因1.5 mg/kg,C组产妇给予质量浓度为2.5 g/L的罗哌卡因1.5 mg/kg,同时给予所有产妇镇痛泵辅助镇痛。记录观察所有产妇术后6 h、12 h、24 h、36 h、48 h的疼痛视觉模拟评分(VAS)、镇痛泵按压次数、产妇对镇痛效果的满意程度以及腹横肌平面阻滞(TAP)不良反应发生情况。结果 B、C组产妇的VAS评分均低于A组产妇(P<0.05),24 h后C组产妇的VAS评分低于B组产妇(P<0.05);与B、C组产妇相比,A组产妇的镇痛泵按压次数更多,镇痛效果满意度较低(P<0.05),同时B组产妇的镇痛泵按压次数多于C组产妇(P<0.05);3组产妇均未出现术后不良反应。结论 使用质量浓度为2.5 g/L的罗哌卡因横纹肌阻滞进行剖宫产术后镇痛,效果显著、安全性较高,临床中可推广使用。
Objective To compare the clinical effects of different concentrations of ropivacaine for postoperative analgesia after cesarean section. Methods 300 cases of pregnant women undergoing cesarean section in our hospital from March 2015 to March 2016 were selected and were randomly divided into group A, group B and group C with 100 cases in each group. The patients in group A were given 0.15% ropivacaine 1.5 mg/kg, 0.20% ropivacaine 1.5 mg/kg in group B and 0.25% ropivacaine 1.5 mg/kg in group C, and at the same time all the pregnant women were given analgesic pump assisting analgesia. The pain visual analogue scales (VAS) of the pregnant women were recorded at 6 hours, 12 hours, 24 hours and 36 hours after cesarean section and the number of times of analgesia pressing pump were also recorded. The satisfaction degree of analgesic effect and the TAP occurrence of adverse reactions of the patients were also recorded. Results The VAS scores of group B and group C were lower than that of group A(P<0.05). 24 hours after cesarean section, the VAS score of group C was lower than that of group B (P<0.05). Compared with group B and C, the number of times of analgesia pressing pump in group A were more but the analgesic effect of satisfaction was lower (P<0.05), and at the same time the number of times of analgesia pressing pump in group B were more than those in group C (P<0.05). No adverse reactions were found in the three groups. Conclusion The treatment of using of 0.25% of ropivacaine for muscle block for postoperative analgesia after cesarean section is effective and safe, which may be widely used in clinical practice.
临床诊疗

小剂量丙泊酚抑制无痛人工流产术孕者应激反应的临床观察

Observation of Small Dose Propofol in Control of Stress Reaction in Analgesia Artilicial Abortion Opration

:84-85
 
目的 观察对应手术时点小剂量丙泊酚抑制无痛人工流产手术孕者应激反应的有效性。方法 选择门诊自愿在全麻下行无痛人工流产手术的早孕妇女80例,ASAⅠ或Ⅱ级,随机分为前臂头静脉组(A组)、下肢踝前大隐静脉组(B组)。两组早孕者分别在抬臀铺入无菌臀巾时(T1)、置入窥器即刻(T2)、钳夹宫颈即刻(T3)时点,推注不同剂量丙泊酚,观察记录麻醉效果相关指标。结果 A组追加丙泊酚次数与B组相比少(P<0.01),A组丙泊酚用量与B组相比减少(P<0.01),A组术毕到唤醒睁眼的时间与B组相比缩短,差异有统计学意义(P<0.01)。结论 对应手术操作时点经上肢头静脉小剂量推注丙泊酚能较好的抑制无痛人工流产手术孕者应激反应,且苏醒快,并发症少。
出版者信息








《广州医药》公众号